6th Jan 2022 09:50
(Alliance News) - Goldman Sachs International confirmed on Thursday that IngreLux Sarl, a company owned by funds advised by London-based private equity firm Permira Advisers LLP, sold a 6.5% stake in boot maker Dr Martens PLC.
Goldman Sachs said it placed 65 million Dr Marten shares at 395 pence each, raising GBP257 million for the seller. Shares in Dr Martens were 8.6% lower at 385.00p early Thursday in London.
IngreLux had owned 429.1 million shares in the Wollaston, Northamptonshire-based footwear and clothing maker, about a 43% stake, and now has 364.1 million, a 36.4% holding. IngreLux is subject to a 90 lock-up period for the remaining shares.
Barclays Bank PLC was joint bookrunner for the placing. Dr Martens will not receive any proceeds from the placing as it was of existing shares.
By Tom Waite; [email protected]
Copyright 2022 Alliance News Limited. All Rights Reserved.
Related Shares:
BarclaysDr. Martens